December 3, 2017
Six California prisoners wrote to me in 2015 to ask about the Hepatitis C cure, shortly after the San Francisco Bay View newspaper published my interview with activist attorney Peter Erlinder titled “US prisoners sue for constitutional right to lifesaving Hep C cure.” They’d been able to read it because the Bay View sends a print edition to prisons all over the country every month. I tried and failed to answer those letters and I’ve felt bad about it ever since. I would have swiftly responded to all the prisoners who wrote to me about the Hep C cure if I’d been able to send electronic mail.
June 27, 2015
Attorneys filed lawsuits in Pennsylvania and Massachusetts this week on behalf of prisoners who say they’re being denied new lifesaving treatment for Hepatitis C because of the cost of the drugs. Gilead Sciences manufactures two versions of the cure, Harvoni and Sovaldi. Abbvie Pharmaceutical Limited, formerly Abbot Labs, manufactures another, Viekira Pak. The cost of any one of the three is roughly $90,000.